<DOC>
	<DOCNO>NCT01521507</DOCNO>
	<brief_summary>The study objective evaluate long-term treatment effectiveness adult patient meibomian gland dysfunction ( MGD ) evaporative dry eye : 1 ) compare LipiFlow® System standardize daily warm compress eyelid hygiene control therapy duration 3 Months ; 2 ) evaluate LipiFlow® alone combination MGD dry eye treatment duration 12 Months . This post-market , non-significant risk , prospective multi-center clinical trial divide two stage . The first stage enrollment 3 Months open-label , randomize control design compare effectiveness single LipiFlow® System treatment standardize daily warm compress eyelid hygiene Control therapy Crossover LipiFlow® treatment Control subject 3 Months . The second stage , occur 3 12 Months , observational design evaluate effectiveness LipiFlow® alone combination MGD dry eye treatment duration 12 Months . Subjects enter follow subgroup base subject 's self-assessment adequacy symptom relief protocol-defined criterion additional treatment . 1 . One LipiFlow® Treatment : Subjects receive one LipiFlow® treatment . 2 . Two LipiFlow® Treatments : Subjects receive second LipiFlow® treatment . 3 . Combination Treatment : Subjects receive one two LipiFlow® treatment follow MGD dry eye treatment , prescribed physician .</brief_summary>
	<brief_title>Randomized Controlled Trial Long-term Treatment Effectiveness Meibomian Gland Dysfunction ( MGD ) Dry Eye</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<criteria>At least 18 year old Tear film assessment qualifies eye Evidence meibomian gland dysfunction dry eye eye Willingness comply study protocol Systemic disease condition medication cause dry eye Use treatment MGD dry eye Ocular surgery , trauma , herpes infection , punctal plug insertion punctal occlusion within past 3 month Active eye infection Active eye inflammation recurrent inflammation within past 3 month Moderate severe allergic conjunctivitis Severe eyelid inflammation Eyelid abnormality affect lid function Ocular surface abnormality may compromise corneal integrity Pregnant nursing woman Participation another ophthalmic clinical trial within past 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>